CKD screening at age 55, combined with SGLT2 inhibitors, reduces kidney failure incidence and improves life expectancy across racial and ethnic groups. Non-Hispanic Black adults experience the most ...
A study published in JAMA Internal Medicine in 2023 concluded most common cancer screening tests do not “save lives by extending lifetime.”A new evaluation of the data used in that meta-analysis found ...
Yingye Zheng, Douglas A. Corley, Chyke Doubeni, Ethan Halm, Susan M. Shortreed, William E. Barlow, Ann Zauber, Tor Devin Tosteson, Jessica Chubak The Annals of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback